Skip to main content
SpringerLink
Log in

Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment

  • Letter to the Editor
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cara AKS, Zaidi STR, Suleman F. Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia. Int J Clin Pharm. 2018;40(5):1051–8.

    Article  CAS  PubMed  Google Scholar 

  2. Kalin G, Alp E, Coskun R, Demiraslan H, Gündogan K, Doganay M. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? J Infect Chemother. 2012;18(6):872–7.

    Article  CAS  PubMed  Google Scholar 

  3. Zaidi STR, Al Omran S, Al Aithan ASM, Al Sultan M. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. J Clin Pharm Ther. 2014;39(3):272–6.

    Article  CAS  PubMed  Google Scholar 

  4. Musher DM. Clinical and microbiological end points in the treatment of pneumonia. Clin Infect Dis. 2008;47(Supplement_3):S207–9.

    Article  PubMed  Google Scholar 

Download references

Funding

Conflicts of interest

The authors have nothing to declare.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

    Effat Davoudi-Monfared

  2. Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, 4th Floor, No 92, Karimkhan Zand Ave, Hafte Tir Sq, Tehran, Iran

    Maryam Taghizadeh-Ghehi

Authors
  1. Effat Davoudi-Monfared
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Taghizadeh-Ghehi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maryam Taghizadeh-Ghehi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Davoudi-Monfared, E., Taghizadeh-Ghehi, M. Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment. Int J Clin Pharm 41, 621–622 (2019). https://doi.org/10.1007/s11096-019-00822-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-019-00822-6

Search

Navigation